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This paper evaluates the association of oxidative stress and atherogenic index of plasma in order to assess the cardiovascular
risk in Sickle cell nephropathy especially as lipoprotein levels are lower in SCD than non-SCD patients. Antioxidant enzymes,
malondialdehyde(MDA), urea, creatinine, and glomerular ﬁltration rate were evaluated in 110 conﬁrmed sickle cell disease
patients:65malesinsteadystate,aged21.1±6.0years,30maleswithmacroalbuminuria,aged24.5±7.0,yearsand15withchronic
kidney disease (CKD), aged 31.8 ± 2.0 years. The mean activity levels of glutathione peroxidase (GPx), superoxide dismutase
(Cu/ZnSOD), and catalase (CAT) were signiﬁcantly lower (P<0.001) in SCD with macroalbuminuria and CKD while MDA was
higher (P<0.001) in SCD with macroalbuminuria and CKD compared with controls. There was negative correlation between
GPx (P<0.001), Cu/ZnSOD (P<0.02), and Atherogenic index of plasma in SCD with CKD, while MDA shows a positive
correlation (P<0.001) with AIP in SCD with CKD. There was however no correlation between CAT and AIP. Decreased activity
levels of antioxidant enzymes and low HDL-cholesterol concentration were conﬁrmed in adult SCD with CKD in Nigerians. The
increase oxidative stress and high atherogenic index in CKD may accelerate the process of cardiovascular complications in adult
SCD patients. Atherogenic index of plasma was negatively correlated with antioxidant enzymes and positively with MDA.
1.Introduction
Sickle cell disease (SCD) is a haemoglobinopathy which
is characterized by red blood cell rigidity, compromised
perfusions, and tissue infarction [1]. The kidney of patients
w i t hS C Di sa ﬀected both by haemodynamic changes of
chronic and by consequences of vaso-occlusion within the
renal medulla [2, 3]. Renal abnormalities in structure and
function occur with increasing age of subject with SCD.
The pathogenesis of SCD is due to polymerization of
sickle red blood cell causing chronic haemolytic anaemia,
vaso-occlusive crisis, and intravascular haemolysis. Sickle
cell disease patients are susceptible to increased oxidative
stress due to constant haemolysis of mutant red blood cells
since haemoglobin acts as powerful catalyst for initiation
of peroxidative reaction [4, 5]. Proteinuria is common in
adult patients with SCD and we earlier reported a 28%
prevalence of proteinuria in this group of patients in Nigeria
[6]. Proteinuria is a progression factor in chronic kidney
disease heralding a further deterioration in renal function
[6]. Metabolic abnormalities, inﬂammation, and ischaemia
may increase oxidative stress in sickle cell nephropathy
(SCN). Increased oxidative stress in SCN due to increased
pro-oxidative activity may lead to diminished antioxidant
system [4, 7]. Increased oxidative stress is considered as
an important pathogenic mechanism in the development
of cardiovascular, cerebrovascular, and peripheral vascular
complications [8, 9]. Autoperoxidation of polyunsaturated
fatty acids (PUFAs) is initiated by free radicals, and the
products which are oxidized in vivo to form malondialde-
hyde are capable of damaging membrane of biomolecules
[9, 10]. Lipid abnormalities and increased oxidative stress in2 Anemia
Table 1: Biochemical and lipid proﬁle of sickle cell disease controls, macroalbuminuria, and chronic kidney disease.
Variables SCD controls SCD macroalbuminuria SCD CKD Reference range
Number of subjects 65 30 15
Age (years) 21.1 ±6.02 4 .5 ±7.03 1 .8 ±2.0∗
Urea (mmol/L) 2.6 ±0.98 .3 ±2.0∗ 14.2 ±2.6∗ 1.7–8.3
Creatinine (µmol/L) 57.3 ±9.8 260 ± 25∗ 498 ± 75∗ 53–116
eGFR (mL/min) 101 ± 2.3 72 ± 5.0∗ 15.1 ±2.0∗ 90–128
Triglyceride (mmol/L) 1.16 ±0.41 .20 ±0.21 .7 ±0.25∗ <1.7
Total cholesterol (mmol/L) 3.06 ±0.53 .45 ±0.6∗ 3.9 ±0.34∗ 3.1–6.2
HDL-cholesterol (mmol/L) 0.72 ±0.20 .70 ±0.30 .06 ±0.08∗ 0.8–1.9
LDL-cholesterol (mmol/L) 1.90 ±0.51 .8 ±0.32∗ 1.82 ±0.06∗ <3.99
VLDL-cholesterol (mmol/L) 0.47 ±0.06 0.52 ±0.06∗ 0.74 ±0.06∗ <0.8
AIP 0.22 0.23 0.45 <1.44
TC: HDL 4.25 4.92 6.50 <4.9
LDL: HDL 2.67 2.57 3.03 <2.4
eGFR: estimated glomerular ﬁltration rate; AIP: atherogenic index of plasma; ∗P<0.001.
SCN may accelerate the process of atherosclerosis in patients
with SCN. This study evaluates the association of oxidative
stress and atherogenic index of plasma in order to assess the
cardiovascular risk in SCN especially when lipoprotein levels
are lower in SCD than non-SCD patients.
2.MaterialsandMethods
The study population was 110 conﬁrmed SCD patients
attending sickle cell disease clinic of Aminu Kano Teaching
Hospital. They consisted of 65 males in steady state, aged
21.1±6.0years,30maleswithmacroalbuminuriaaged24.5±
7.0 years, and 15 with chronic kidney disease (CKD), aged
31.8 ± 2.0 years. Demographic and clinical examination
ﬁndings were obtained using structured questionnaires. The
study protocol used was approved by the institute’s ethical
committee and the patients gave informed consent before
enrolment in the study. Random urine was obtained for
analysis using combi-9 commercial dipstick, which was used
to test for biochemical urinalysis. Five milliliter of blood
was collected aseptically and dispensed into a plain tube
after 12-hour fast. The blood was allowed to clot and serum
obtained after centrifugation at 3000rpm for 10minutes.
The sera were stored at −20◦C and analysis was done
within two weeks of collection. Urea was determined using
urease colorimetric technique, creatinine was assayed using
sodium hydroxide-picric acid technique, and superoxide
dismutase (Cu/ZnSOD), and glutathione peroxidase (GPx)
were assayed using ELISA kits supplied by Northwest life
science specialities, Vancouver, Canada. Catalase was esti-
mated using kit by SIGMA (St. Louis, Missouri, USA) and
malondialdehyde was determined using thiobarbituric acid
reacting substance kit supplied by Northwest life science
specialties. Total cholesterol and triglyceride (TG) were
determined using enzyme-catalyzed colorimetric methods
by Randox laboratories, UK. HDL cholesterol was assayed
using the supernatant after precipitation with magnesium
chloride-phosphotungstic acid solution, while LDL choles-
terol was calculated using Friedewald formula [11]. Cardio-
vascular risk ratio was calculated using atherogenic index
of plasma (AIP) [12], which was deﬁned as log(TG/HDL-
c) with TG and HDL-c expressed in molar concentration.
Glomerular ﬁltration rate was estimated using Cockroft-
Gault formular [13]. Chronic kidney disease was deﬁned as
estimated glomerular ﬁltration rate (eGFR) of <60mL/min
and presence of macroalbuminuria. Macroalbuminuria was
deﬁned as presence in urine of albumin concentration of
≥300mg/L. A two-sample t-test was used to determine the
statistical signiﬁcance of the means between the diﬀerent
groups. A P value of 0.05 or less was considered statistically
signiﬁcant. Pearson correlation coeﬃcient was used to show
the levels of association of antioxidant enzyme levels with
AIP in SCD patient with CKD.
3. Results
The results are as indicated in Tables 1, 2,a n d3. Table 1
shows biochemical and lipoprotein levels of SCD subjects in
steady state used as controls, SCD with macroalbuminuria,
and CKD. The mean serum urea and creatinine in SCD
with macroalbuminuria and CKD were signiﬁcantly higher
(P<0.001) than those of the SCD control subjects while
the mean eGFR was signiﬁcantly lower (P<0.001) in SCD
with macroalbuminuria and CKD compared with control
subjects. The mean levels of triglyceride, total cholesterol,
LDL cholesterol, and VLDL cholesterol were signiﬁcantly
higher (P<0.001) in CKD compared with SCD controls
while HDL cholesterol was lower (P<0.001) in CKD
compared with control subjects. The atherogenic index
signiﬁcantly increased in SCD patients with CKD compared
with SCD with macroalbuminuria and control group.
Table 2 indicates changes in oxidative stress markers in
thestudygroup.ThemeanactivitylevelsofGPx,Cu/ZnSOD,
and CAT were signiﬁcantly lower (P<0.001) in SCD
with macroalbuminuria and CKD while MDA was higherAnemia 3
Table 2: Oxidative stress markers of sickle cell disease control, macroalbuminuria, and chronic kidney disease.
Oxidative markers SCD controls SCD with
macroalbuminuria
SCD with chronic
kidney disease Reference range
Number of subjects 65 30 15
Glutathione peroxidase (mU/mL) 9.2 ±0.95 .54 ±3.5∗ 3.01 ±0.24∗ 9.2–19.6
Superoxide dismutase (ng/mL) 30.6 ±5.12 1 .3 ±5.2∗ 18.5 ±2.6∗ 22.5–103
Catalase (µmol/min/L) 154 ± 7.9 150 ± 2.58 147 ± 1.06∗ 156–182
Malondialdehyde (µmol/L) 2.5 ±0.43 .8 ±1.7∗ 5.30 ±0.3∗ 0.025–0.98
∗P<0.001.
Table 3:Correlationbetween antioxidantenzymesandatherogenic
index of plasma in SCD with chronic kidney disease.
Correlation between parameters R value P value
GPx and AIP −0.760 0.001
Cu/ZnSOD and AIP −0.621 0.02
CAT and AIP −0.416 NS
MDA and AIP 0.943 0.001
GPx: Glutathione peroxidase; Cu/ZnSOD: Superoxide Dismutase; CAT:
Catalase and MDA: Malondialdehyde.
(P<0.001) in SCD with macroalbuminuria and CKD
compared with controls.
Table 3 shows the levels of association of antioxidant
markers with AIP in SCD with CKD. There were negative
correlations between GPx (P<0.001), Cu/ZnSOD (P<
0.02), and AIP in SCD with CKD, while MDA shows a
positive correlation (P<0.001) with AIP in SCD with
CKD. The correlation between CAT and AIP was however
not signiﬁcant.
4. Discussion
The data showed that there were increases in oxidative stress
and lipoprotein levels in SCD patients with macroalbumin-
uria and CKD. Atherogenic index of plasma was negatively
correlated with antioxidant enzymes and positively with
MDA in CKD. Studies have shown decreases in the activity
levels of antioxidant enzymes in SCD patients in steady state
[4] and in non-SCD patients with acute renal failure [14].
The present study associated the decreases in the antioxidant
enzyme activity levels with AIP, used as cardiovascular risk,
especially as lipoprotein levels in SCD patients are lower
than non-SCD individuals in both normal and renal disease.
In this study, we observed increased oxidative stress in
SCD patients with CKD. Oxidative damage is due to redox
imbalance between production of reactive oxygen species
(ROS) and the countering eﬀects of the various antioxidants
in the body. The increased production of ROS in SCD can
be grossly ampliﬁed in response to a variety of pathophysio-
logical conditions including renal disorders, inﬂammation,
immunologic disorders, hypoxia, metabolism of drugs or
alcohol, and deﬁciency in antioxidant enzymes [1, 4, 15].
Reactive oxygen species can cause signiﬁcant damage to
biomolecules since membrane lipids readily react with ROS
resulting in lipid peroxidation [16–18]. Increased oxidative
stress has been reported to mediate most of the risk factors
involved in kidney disease [19]. Free radical mediated injury
is the primary event leading to renal injury and progressive
renal insuﬃciency and may lead to increased levels of lipid
peroxidation. This occurs because cell membrane contains
large quantity of PUFAs. These PUFAs react with ROS to
form peroxide derivatives [20, 21]. Oxidative damage may
alter both structure and function of the glomerulus due to
its eﬀects on mesangial and endothelial cells. Overexpression
of ROS by both enzymatic and nonenzymatic pathways
(Fenton chemistry) promotes intravascular oxidant stress
that can disrupt nitric oxide homeostasis and produce the
highly oxidative peroxynitrite [22]. Previous reports have
showedthatrenaldiseaseinSCDhasthecapacitytodiminish
arginine bioavailability through the loss of de novo arginine
synthesis from citrulline which occurs primarily in the
kidneys. Renal insuﬃciency may impair the major route for
endogenous arginine biosynthesis [23] since it plays some
roles in the regulation of nitric oxide production [24].Adults
with SCD are arginine deﬁcient even at steady state [25, 26].
The observed increases (P<0.001) in the levels of
serum triglyceride, LDL, VLDL, and decrease (P<0.001)
of HDL-cholesterol levels in SCD patients with CKD are
consistent with other studies elsewhere and in Nigeria [27–
30]. The lipid proﬁle of SCD patients is quite lower than
that in subjects with normal haemoglobin and SCD patients
in Nigeria have even lower levels than SCD patients in
America and the Middle East [27–29]. Several reasons have
been proposed as to why there are inconsistencies between
lipid studies; these include diﬀerences in age, diet, weight,
smoking, gender, small sample sizes, diﬀerent ranges of
disease severity, and treatment regimen [31–33]. Shores et
al. [28] proposed the reasons why lipoprotein levels are
lower in SCD than nonSCD even in the same environmental
condition to be partly due to a decrease in red blood cell
volume leading to a dilution eﬀect on plasma constituents.
It may also result from strong downregulation of the
syntheticpathwaysordownregulationoftheenzymesinlipid
biosynthesis. Others suggested that it is the haemolytic stress
inSCDpatientsthatisassociatedwithasigniﬁcantreduction
in plasma lipids in SCD patients [29, 34].
5. Conclusion
Decreased activity levels of antioxidant enzymes and low
HDL-cholesterol concentration were conﬁrmed in adult
SCD with CKD in Nigerians. The increase oxidative stress4 Anemia
and high atherogenic index in CKD may accelerate the pro-
cess of cardiovascular complications in adult SCD patients.
Atherogenic index of plasma was negatively correlated with
antioxidant enzymes and positively with MDA.
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